Cargando…

IL-6 blockade in systemic juvenile idiopathic arthritis – achievement of inactive disease and remission (data from the German AID-registry)

BACKGROUND: Systemic juvenile idiopathic arthritis (sJIA) is a complex disease with an autoinflammatory component of unknown etiology related to the innate immune system. A major role in the pathogenesis has been ascribed to proinflammatory cytokines like interleukin-6 (IL-6), and effective drugs in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bielak, M., Husmann, E., Weyandt, N., Haas, J.-P., Hügle, B., Horneff, G., Neudorf, U., Lutz, T., Lilienthal, E., Kallinich, T., Tenbrock, K., Berendes, R., Niehues, T., Wittkowski, H., Weißbarth-Riedel, E., Heubner, G., Oommen, P., Klotsche, J., Foell, Dirk, Lainka, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887199/ https://www.ncbi.nlm.nih.gov/pubmed/29622022 http://dx.doi.org/10.1186/s12969-018-0236-y

Ejemplares similares

Interleukin (IL)- 6 inhibition - Follow-up data of the German AID-registry(1)
por: Bielak, M, et al.
Publicado: (2015)

Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis – data from the German AID-registry
por: Lainka, Elke, et al.
Publicado: (2021)

PReS-FINAL-2216: Biomarkers MRP8/14 and S100A12 correspond with flare and remission clinical status in Sojia patients in the AID-NET register
por: Gohar, F, et al.
Publicado: (2013)

PReS-FINAL-2215: Genotype-phenotype correlations in children with Familial Mediterranean Fever in Germany
por: Gohar, F, et al.
Publicado: (2013)

P01-008 – FMF genotype-phenotype correlations in Germany
por: Jeske, M, et al.
Publicado: (2013)

Colchicine therapy in children with FMF
por: Knieper, A-M, et al.
Publicado: (2015)

PReS-FINAL-2152: Biomarkers as predictors of early inactive disease in children with juvenile idiopathic arthritis
por: Lavric, M, et al.
Publicado: (2013)

Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany
por: Hinze, Claas H., et al.
Publicado: (2018)

Increased Prevalence of NLRP3 Q703K Variant Among Patients With Autoinflammatory Diseases: An International Multicentric Study
por: Theodoropoulou, Katerina, et al.
Publicado: (2020)

PW02-041 - Canakinumab treatment regimens in CAPS-patients
por: Hofer, F, et al.
Publicado: (2013)

PReS-FINAL-2224: Canakinumab treatment regimens in CAPS-patients
por: Hofer, F, et al.
Publicado: (2013)

Participation in school sports among children and adolescents with juvenile idiopathic arthritis in the German National Paediatric Rheumatologic Database, 2000–2015: results from a prospective observational cohort study
por: Milatz, Florian, et al.
Publicado: (2019)

Canakinumab treat-to target strategies increase complete response rate in CAPS
por: Kuemmerle-Deschner, J, et al.
Publicado: (2015)

Infection with SARS-CoV-2 causes flares in patients with juvenile idiopathic arthritis in remission or inactive disease on medication
por: Hügle, Boris, et al.
Publicado: (2021)

The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF)
por: Wittkowski, H, et al.
Publicado: (2008)

PW01-008 – The inflammasome and secretory pathways in FMF
por: Orak, B, et al.
Publicado: (2013)

Aktualisierte Handlungsempfehlung nach der S2k-Leitlinie Kawasaki-Syndrom
por: Hospach, T., et al.
Publicado: (2022)

Breaking down the fences among registries on autoinflammatory diseases: the E-Merge project
por: Vyzhga, Y., et al.
Publicado: (2023)

Atypical clinical presentation of a severe Tumor Necrosis Factor Receptor-associated Periodic Syndrome (TRAPS) without mutation in the TNFRSF1A gene and good response to anakinra. Case report of a ten year old girl with fever, skin edema and abdominal pain (AID-registry)
por: Hamsen, F, et al.
Publicado: (2015)

Differences in the severity of the phenotype of children and adolescents with Familial Mediterranean Fever residing in Turkey and Germany
por: Ayaz, N Aktay, et al.
Publicado: (2008)

Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria
por: Hinze, Claas H., et al.
Publicado: (2018)

The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort
por: Sengler, Claudia, et al.
Publicado: (2015)

The German version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Holzinger, Dirk, et al.
Publicado: (2018)

Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab
por: Horneff, Gerd, et al.
Publicado: (2016)

Physical activity, inactivity and sleep during the Diabetes Remission Clinical Trial (DiRECT)
por: Cassidy, Sophie, et al.
Publicado: (2022)

Treat-to-target strategies for the management of familial Mediterranean Fever in children
por: Ehlers, Lisa, et al.
Publicado: (2023)

Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course
por: Hügle, Boris, et al.
Publicado: (2014)

Adherence, helpfulness and barriers to treatment in juvenile idiopathic arthritis – data from a German Inception cohort
por: Kirchner, Sabine, et al.
Publicado: (2023)

Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial
por: Alexeeva, Ekaterina, et al.
Publicado: (2021)

Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline
por: Ganeva, Margarita, et al.
Publicado: (2021)

PW01-009 – Markers of inflammation in adult FMF patients
por: Giese, A, et al.
Publicado: (2013)

Medication burden in young adults with juvenile idiopathic arthritis: data from a multicentre observational study
por: Montag, Laura J, et al.
Publicado: (2022)

Fluorescence optical imaging in pediatric patients with inflammatory and non-inflammatory joint diseases: a comparative study with ultrasonography
por: Beck, Marisa Christin, et al.
Publicado: (2017)

Defining clinical remission and clinically inactive disease in juvenile systemic lupus erythematosus (jSLE)
por: Mina, Rina, et al.
Publicado: (2011)

Inactive disease and remission rates after intraarticular steroids as initial therapy for juvenile idiopathic arhtritis (JIA)
por: Sato, JO, et al.
Publicado: (2011)

The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON)
por: Listing, Miriam, et al.
Publicado: (2018)

Characterization of inactive carbon in GaAs
por: Moll, A J, et al.
Publicado: (1994)

Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis
por: Schiappapietra, B, et al.
Publicado: (2011)

Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany
por: Sengler, Claudia, et al.
Publicado: (2021)

Outcome of adult patients with JIA treated with the biosimilar Benepali(®): results of the biologic register JuMBO
por: Vollbach, Kristina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pciabuv5svuqq3loilg6662523